Roche’s Virtual Event following Angiogenesis 2021
Roche has hosted a virtual event on Tuesday, 16th February 2021.
Agenda:
- Welcome
Karl Mahler, Head of Investor Relations and Roche Group Planning - Ophthalmology Strategy Update
Atul Dandekar, Vice President and Global Franchise Head of Ophthalmology Product Strategy - Ophthalmology Pipeline Update
Christopher Brittain, Vice President and Global Head of Ophthalmology Product Development - Faricimab in DME and nAMD – Phase III results
Nancy Holekamp, M.D., Retina Specialist and Clinical Investigator -
Q&A
Please register to access the webcast replay.*